Showing results (531-540 of 591) with videos related to

Sort By:
Pageof 60
Cancer Immunity|August 21, 2007
A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinomaIan D Davis, Gregory A Wiseman, Fook-Thean Lee, et al.
Blood|October 7, 2006
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantationDjordje Atanackovic, Julia Arfsten, Yanran Cao, et al.
International Journal of Cancer|February 6, 2007
Antibody response against NY-ESO-1 in CHP-NY-ESO-1 vaccinated patientsRyohei Kawabata, Hisashi Wada, Midori Isobe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulanShigehisa Kitano, Shinichi Kageyama, Yasuhiro Nagata, et al.
International Journal of Cancer|August 30, 2008
Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccinationHisashi Wada, Eiichi Sato, Akiko Uenaka, et al.
Cancer Research|June 4, 2009
Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancerFeng Qian, Jeannine Villella, Paul K Wallace, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2011
MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivinTricia Nardiello, Achim A Jungbluth, Anna Mei, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2011
124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PETJoseph A O'Donoghue, Peter M Smith-Jones, John L Humm, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2005
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancerEiichi Sato, Sara H Olson, Jiyoung Ahn, et al.
The Journal of Clinical Investigation|January 27, 2007
Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant-dependent lung carcinomasDanan Li, Hongbin Ji, Sara Zaghlul, et al.
Pageof 60